New drug pricing policy crucial for stocks: Nirmal Bang Institutional Equities
PUBLISHED ON: September 27, 2012 | Duration: 5 min, 41 sec
The drug pricing policy is crucial for consumers and also almost all listed drug companies in India. Praful Bohra, Sr. Research Analyst-Pharmaceuticals, Nirmal Bang Institutional Equities talks about his thoughts on the subject and how this might play out.
